Company

Jiangsu Lianhuan Pharmaceutical Co. Ltd

Headquarters: Yangzhou, China

SSE: 600513 +6.35%

Market Cap

CN¥3.09 Billion

CNY as of July 1, 2025

US$430.7 Million

Market Cap History

Jiangsu Lianhuan Pharmaceutical Co. Ltd Categories

China Healthcare Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Jiangsu Lianhuan Pharmaceutical Co. Ltd market capitalization over time

Evolution of Jiangsu Lianhuan Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Jiangsu Lianhuan Pharmaceutical Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.

Stocks & Indices

Jiangsu Lianhuan Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 600513 wb_incandescent

Details

Headquarters:

No. 21, Wenfeng Road

Yangzhou, 225009

China

Phone: 86 514 8781 1291

Fax: 86 514 8781 5079